Robert Hauser, MD, MBA, discusses how the patient experience is defined in Parkinson disease.
Minimizing Variations in Patient’s Experience with Levodopa Therapy in Parkinson's Disease
Robert Hauser, MD, MBA, reviews the predictability of dyskinesia and OFF episodes in Parkinson disease.
Robert Hauser, MD, MBA, shares his expertise in the treatment of OFF time in Parkinson disease.
Robert Hauser, MD, MBA, talks about amantadine extended release for management of dyskinesia and OFF episodes.
Robert Hauser, MD, MBA, discussed unmet needs and future consideration in Parkinson disease.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Stem Cells of Secondary Progressive Multiple Sclerosis Drive Increased Proinflammatory T-Cell Activity
2
Insights Into the Neurobiology of Stuttering From 2025 STARS Conference: Shahriar SheikhBahaei, PhD
3
Daridorexant Provides Relief for Insomnia in Women During Menopausal Transition
4
EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits
5
